Pricing
Login
Home
Charts
Search
Watchlist
Products

Amrutanjan Health Care Ltd

AMRUTANJAN
₹512.65-0.85%20 Nov 2026
Reports
Pharma Formulations

Amrutanjan Health Care Ltd

AMRUTANJAN
₹512.65
-0.85%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹1,482Cr
Close
Close Price
₹512.65
Industry
Industry
Pharma Formulations
PE
Price To Earnings
25.87
PS
Price To Sales
2.80
Revenue
Revenue
₹529Cr
Rev Gr TTM
Revenue Growth TTM
12.57%
PAT Gr TTM
PAT Growth TTM
1.04%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
1171278411012313594118141150103135
Growth YoY
Revenue Growth YoY%
19.826.67.510.74.96.612.37.114.910.69.514.8
Expenses
ExpensesCr
951118096991188610111612497112
Operating Profit
Operating ProfitCr
221641423188172526624
OPM
OPM%
18.412.84.312.419.013.19.014.017.917.16.117.5
Other Income
Other IncomeCr
454445443-323
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
222222222223
PBT
PBTCr
2420616262111192621623
Tax
TaxCr
662476357526
PAT
PATCr
171451219158141916417
Growth YoY
PAT Growth YoY%
62.97.6-34.172.310.311.179.918.31.06.7-47.423.8
NPM
NPM%
14.910.85.510.715.711.28.811.913.810.84.212.8
EPS
EPS₹
6.04.71.64.16.75.32.94.86.75.61.56.0
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
1171278411012313594118141150103135
Growth YoY
Revenue Growth YoY%
19.826.67.510.74.96.612.37.114.910.69.514.8
Expenses
ExpensesCr
951118096991188610111612497112
Operating Profit
Operating ProfitCr
221641423188172526624
OPM
OPM%
18.412.84.312.419.013.19.014.017.917.16.117.5
Other Income
Other IncomeCr
454445443-323
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
222222222223
PBT
PBTCr
2420616262111192621623
Tax
TaxCr
662476357526
PAT
PATCr
171451219158141916417
Growth YoY
PAT Growth YoY%
62.97.6-34.172.310.311.179.918.31.06.7-47.423.8
NPM
NPM%
14.910.85.510.715.711.28.811.913.810.84.212.8
EPS
EPS₹
6.04.71.64.16.75.32.94.86.75.61.56.0

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
184207220253261333406380421452503529
Growth
Revenue Growth%
12.912.26.315.13.327.321.9-6.511.07.311.212.6
Expenses
ExpensesCr
153177192222231258326335369394427448
Operating Profit
Operating ProfitCr
323028313175794452587681
OPM
OPM%
17.114.512.812.311.822.519.611.712.312.915.115.2
Other Income
Other IncomeCr
67878111515161895
Interest Expense
Interest ExpenseCr
000001000000
Depreciation
DepreciationCr
323344456769
PBT
PBTCr
353533353482915462697877
Tax
TaxCr
12121310921231417182019
PAT
PATCr
222320252561674045515857
Growth
PAT Growth%
31.03.1-13.224.70.3143.99.8-40.712.913.013.91.0
NPM
NPM%
12.211.29.19.99.618.416.610.510.711.311.510.8
EPS
EPS₹
7.77.53.48.48.620.923.113.715.517.620.019.8
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
184207220253261333406380421452503529
Growth
Revenue Growth%
12.912.26.315.13.327.321.9-6.511.07.311.212.6
Expenses
ExpensesCr
153177192222231258326335369394427448
Operating Profit
Operating ProfitCr
323028313175794452587681
OPM
OPM%
17.114.512.812.311.822.519.611.712.312.915.115.2
Other Income
Other IncomeCr
67878111515161895
Interest Expense
Interest ExpenseCr
000001000000
Depreciation
DepreciationCr
323344456769
PBT
PBTCr
353533353482915462697877
Tax
TaxCr
12121310921231417182019
PAT
PATCr
222320252561674045515857
Growth
PAT Growth%
31.03.1-13.224.70.3143.99.8-40.712.913.013.91.0
NPM
NPM%
12.211.29.19.99.618.416.610.510.711.311.510.8
EPS
EPS₹
7.77.53.48.48.620.923.113.715.517.620.019.8
Sales CAGR
1 Year11%
3 Years10%
5 Years9%
TTM13%
EBITDA CAGR
1 Year30%
3 Years19%
5 Years0%
TTM22%
PAT CAGR
1 Year14%
3 Years13%
5 Years-1%
TTM1%
Avg. ROCE
1 Year21%
3 Years21%
5 Years23%
TTM20%
CFO / EBITDA
1 Year48%
3 Years62%
5 Years60%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
333333333333
Reserves
ReservesCr
118113126143157213262288286324367381
Current Liabilities
Current LiabilitiesCr
25323236395277637085126118
Non Current Liabilities
Non Current LiabilitiesCr
345677788101213
Total Liabilities
Total LiabilitiesCr
149152166188205274350362367421509515
Current Assets
Current AssetsCr
95108121140126223275260296291292305
Non Current Assets
Non Current AssetsCr
5444454880517510271131217210
Total Assets
Total AssetsCr
149152166188205274350362367421509515
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
333333333333
Reserves
ReservesCr
118113126143157213262288286324367381
Current Liabilities
Current LiabilitiesCr
25323236395277637085126118
Non Current Liabilities
Non Current LiabilitiesCr
345677788101213
Total Liabilities
Total LiabilitiesCr
149152166188205274350362367421509515
Current Assets
Current AssetsCr
95108121140126223275260296291292305
Non Current Assets
Non Current AssetsCr
5444454880517510271131217210
Total Assets
Total AssetsCr
149152166188205274350362367421509515

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
218192118915220285136
Investing Cash Flow
Investing Cash FlowCr
10-8-11-14-88-36-219-31-21
Financing Cash Flow
Financing Cash FlowCr
-11-5-9-7-12-7-17-15-48-13-14
Net Cash Flow
Net Cash FlowCr
12323-7-4-13-161
Free Cash Flow
Free Cash FlowCr
2082121189129112115-19
CFO To PAT
CFO To PAT%
95.335.895.484.772.5148.577.750.762.1100.162.1
CFO To EBITDA
CFO To EBITDA%
67.727.568.067.759.2121.665.745.553.987.547.5
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
218192118915220285136
Investing Cash Flow
Investing Cash FlowCr
10-8-11-14-88-36-219-31-21
Financing Cash Flow
Financing Cash FlowCr
-11-5-9-7-12-7-17-15-48-13-14
Net Cash Flow
Net Cash FlowCr
12323-7-4-13-161
Free Cash Flow
Free Cash FlowCr
2082121189129112115-19
CFO To PAT
CFO To PAT%
95.335.895.484.772.5148.577.750.762.1100.162.1
CFO To EBITDA
CFO To EBITDA%
67.727.568.067.759.2121.665.745.553.987.547.5

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
6108637869089641,6612,3201,6811,7891,8641,4311,482
Price To Earnings
Price To Earnings
27.240.839.337.038.527.134.542.239.836.724.725.9
Price To Sales
Price To Sales
3.34.23.63.63.75.05.74.44.34.12.92.8
Price To Book
Price To Book
5.17.56.16.26.07.78.85.86.25.73.93.9
EV To EBITDA
EV To EBITDA
17.827.825.426.430.320.428.136.334.030.618.518.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
62.856.654.050.852.656.053.449.547.348.449.149.1
OPM
OPM%
17.114.512.812.311.822.519.611.712.312.915.115.2
NPM
NPM%
12.211.29.19.99.618.416.610.510.711.311.510.8
ROCE
ROCE%
28.929.825.724.221.538.034.218.421.421.121.020.0
ROE
ROE%
18.620.015.617.115.728.425.313.715.615.615.614.9
ROA
ROA%
15.115.212.113.312.222.319.211.012.312.111.411.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
6108637869089641,6612,3201,6811,7891,8641,4311,482
Price To Earnings
Price To Earnings
27.240.839.337.038.527.134.542.239.836.724.725.9
Price To Sales
Price To Sales
3.34.23.63.63.75.05.74.44.34.12.92.8
Price To Book
Price To Book
5.17.56.16.26.07.78.85.86.25.73.93.9
EV To EBITDA
EV To EBITDA
17.827.825.426.430.320.428.136.334.030.618.518.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
62.856.654.050.852.656.053.449.547.348.449.149.1
OPM
OPM%
17.114.512.812.311.822.519.611.712.312.915.115.2
NPM
NPM%
12.211.29.19.99.618.416.610.510.711.311.510.8
ROCE
ROCE%
28.929.825.724.221.538.034.218.421.421.121.020.0
ROE
ROE%
18.620.015.617.115.728.425.313.715.615.615.614.9
ROA
ROA%
15.115.212.113.312.222.319.211.012.312.111.411.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr2,1431,8411,5931,4821,4031,3821,112
Close PriceClose₹232.151,655.402,312.00512.65584.85209.27469.95
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE67.6833.9925.8724.4330.6496.70
Price To SalesPS1.124.144.042.803.654.607.18
RevenueRevenueCr1,909444395529385301155
Revenue Growth TTMRev Gr TTM%10.6%15.2%10.6%12.6%38.4%6.4%8.7%
PAT Growth TTMPAT Gr TTM%127.6%27.3%64.3%1.0%64.2%-26.6%31.4%
Market CapitalizationMkt CapCr2,1431,8411,5931,4821,4031,3821,112
Close PriceClose₹232.151,655.402,312.00512.65584.85209.27469.95
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE67.6833.9925.8724.4330.6496.70
Price To SalesPS1.124.144.042.803.654.607.18
RevenueRevenueCr1,909444395529385301155
Revenue Growth TTMRev Gr TTM%10.6%15.2%10.6%12.6%38.4%6.4%8.7%
PAT Growth TTMPAT Gr TTM%127.6%27.3%64.3%1.0%64.2%-26.6%31.4%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Sep 26
ResultPPT
Transcript
Summary
Jun 26
ResultPPT
Transcript
Summary
Mar 26
ResultPPT
Transcript
Summary
Dec 25
ResultPPT
Transcript
Summary
Sep 25
ResultPPT
Transcript
Summary
Jun 25
ResultPPT
Transcript
Summary
Mar 25
ResultPPT
Transcript
Summary
Dec 24
ResultPPT
Transcript
Summary
Sep 24
ResultPPT
Transcript
Summary
Jun 24
ResultPPT
Transcript
Summary
Mar 24
ResultPPT
Transcript
Summary
Dec 23
ResultPPT
Transcript
Summary
Sep 23
ResultPPT
Transcript
Summary
Jun 23
ResultPPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
ResultPPT
Transcript
Summary
Sep 22
ResultPPT
Transcript
Summary
Jun 22
ResultPPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
ResultPPT
Transcript
Summary
Sep 21
ResultPPT
Transcript
Summary
Jun 21
ResultPPT
Transcript
Summary
Mar 21
ResultPPT
Transcript
Summary
Dec 20
ResultPPT
Transcript
Summary
Sep 20
ResultPPT
Transcript
Summary
Jun 20
ResultPPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
ResultPPT
Transcript
Summary
Jun 26
ResultPPT
Transcript
Summary
Mar 26
ResultPPT
Transcript
Summary
Dec 25
ResultPPT
Transcript
Summary
Sep 25
ResultPPT
Transcript
Summary
Jun 25
ResultPPT
Transcript
Summary
Mar 25
ResultPPT
Transcript
Summary
Dec 24
ResultPPT
Transcript
Summary
Sep 24
ResultPPT
Transcript
Summary
Jun 24
ResultPPT
Transcript
Summary
Mar 24
ResultPPT
Transcript
Summary
Dec 23
ResultPPT
Transcript
Summary
Sep 23
ResultPPT
Transcript
Summary
Jun 23
ResultPPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
ResultPPT
Transcript
Summary
Sep 22
ResultPPT
Transcript
Summary
Jun 22
ResultPPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
ResultPPT
Transcript
Summary
Sep 21
ResultPPT
Transcript
Summary
Jun 21
ResultPPT
Transcript
Summary
Mar 21
ResultPPT
Transcript
Summary
Dec 20
ResultPPT
Transcript
Summary
Sep 20
ResultPPT
Transcript
Summary
Jun 20
ResultPPT
Transcript
Summary
Load More
Interviews